Showing 103,361 - 103,380 results of 106,674 for search '(( 50 ((mean decrease) OR (we decrease)) ) OR ( 5 ((step decrease) OR (a decrease)) ))', query time: 1.65s Refine Results
  1. 103361
  2. 103362

    Treatment with activated carbon and other adsorbents as an effective method for the removal of volatile compounds in agricultural distillates by Maria Balcerek (3683623)

    Published 2017
    “…The lowest concentrations of these congeners (expressed in mg l<sup>−1</sup> alcohol 100% v/v) were measured in solutions with ethanol contents of 70–80% v/v, while solutions with an alcoholic strength by volume of 40% did not show statistically significant decreases in these compounds in relation the control sample. …”
  3. 103363

    Histograms for comparison between the QA group and the control group. by Qiqi Feng (535984)

    Published 2014
    “…<p>Histogram A was based on the statistical analyses of brain sections with Nissl staining as well as NeuN and Darpp32 immunolabeling. …”
  4. 103364
  5. 103365
  6. 103366

    Prophylactic and therapeutic potential of selected immunomodulatory agents from Ayurveda against coronaviruses amidst the current formidable scenario: an <i>in silico</i> analysis by Anchal Trivedi (9743744)

    Published 2021
    “…Towards SARS-CoV-2 main and papain-like proteases, the affinity decreased as isomeldenin > EGCG > tinosporaside and EGCG > tinosporaside > isomeldenin, respectively. …”
  7. 103367
  8. 103368
  9. 103369
  10. 103370
  11. 103371

    Differences in Gene Expression between Mouse and Human for Dynamically Regulated Genes in Early Embryo by Elo Madissoon (608322)

    Published 2014
    “…Several large-scale studies have been conducted to identify gene expression patterns for the first five days of human development, and many functional studies utilize mouse as a model system. …”
  12. 103372

    Image_1_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”
  13. 103373

    Image_2_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”
  14. 103374
  15. 103375
  16. 103376

    Image_3_Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recove... by Bernardo L. Rapoport (7431842)

    Published 2023
    “…Relative to a group of healthy control subjects (n=45), the median pre-treatment levels of five co-stimulatory (CD27, CD40, GITRL, ICOS, GITR) and three co-inhibitory (TIM-3, CTLA-4, PD-L1) soluble checkpoints were significantly lower in the BC patients vs. controls (p<0.021-p<0.0001; and p<0.008-p<0.00001, respectively). …”
  17. 103377

    Table_1_SEPT6_TRIM33 Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas.docx by Haiying Fu (1285074)

    Published 2021
    “…SEPT6_TRIM33 gene fusion, mutated TP53 and Hippo pathways were significantly associated with poor PFS, and SEPT6_TRIM33 fusion gene and mutated TP53 pathway were independent prognostic factors for B-cell lymphoma. A decreased VAF of TP53 p.Y88C and LATS2 p.F972L was detected in patients with complete response to treatments. …”
  18. 103378

    Image_3_SEPT6_TRIM33 Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas.tif by Haiying Fu (1285074)

    Published 2021
    “…SEPT6_TRIM33 gene fusion, mutated TP53 and Hippo pathways were significantly associated with poor PFS, and SEPT6_TRIM33 fusion gene and mutated TP53 pathway were independent prognostic factors for B-cell lymphoma. A decreased VAF of TP53 p.Y88C and LATS2 p.F972L was detected in patients with complete response to treatments. …”
  19. 103379

    miR-22 directly targets <i>MECOM</i> mRNA to regulate monocyte/macrophage differentiation. by Chao Shen (520343)

    Published 2016
    “…The arrows pointed differentiated monocytes/macrophages. A statistical analysis for counting differentiated monocyte/macrophages in five fields is presented in the right. …”
  20. 103380

    Cell Types and their Rules. by Bryan Shin (17833689)

    Published 2024
    “…Simulation experiments then revealed significantly decreased B-cell responsiveness as levels of background chronic inflammation increased, reproducing the different COVID-19 infection data seen in a VA population.…”